Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities

NCT04864444 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10715

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum
Malaria

Interventions

DRUG: Dihydroartemisinin-piperaquine
DRUG: Primaquine

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]